Holdings
Caligan Partners LP
As of Sep 30, 2026, Caligan Partners LP reported 26 positions worth US$1.63B. Largest: Revolution Medicines, Inc., Liquidia Corporation and Abivax SA. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 1.96M | US$403M | no change | Sep 30, 2026 |
| Liquidia Corporation | 8.12M | US$246M | no change | Sep 30, 2026 |
| Abivax SA | 1.56M | US$154M | no change | Sep 30, 2026 |
| Vaxcyte, Inc. | 2.19M | US$125M | no change | Sep 30, 2026 |
| Exelixis, Inc. | 1.55M | US$90.7M | no change | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 2.5M | US$62.4M | +1,143 | Sep 30, 2026 |
| ADMA Biologics Inc | 5.88M | US$58.9M | +150K | Sep 30, 2026 |
| Immunocore Holdings plc | 1.67M | US$50.6M | new | Sep 30, 2026 |
| Avalo Therapeutics, Inc. | 3.27M | US$50.1M | +104K | Sep 30, 2026 |
| LB Pharmaceuticals Inc | 1.51M | US$49.6M | +71,551 | Sep 30, 2026 |